Loading…
Evolution Pets LLC marketed two unapproved new animal drugs—SeizureGuard Plus and Life Span Arthritis & Mobility Advanced Enzyme Therapy—in violation of the Federal Food, Drug, and Cosmetic Act by making disease treatment and prevention claims on their website and Amazon product listings without FDA approval. The products' names and labeling claims (such as "help preventing Dog Seizures" and references to treating epilepsy) established them as drugs intended for diagnosing, curing, mitigating, treating, or preventing disease in animals, rather than as dietary supplements or cosmetics. The FDA identified these violations during a review of the company's website and third-party retail channels conducted between October and November 2024.